Chemical Structure (Fentanyl 01)
Fentanyl Citrate Injection, Solution
Product Images NDC 0409-9093
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Fentanyl Citrate (NDC 0409-9093). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Logo (Fentanyl 02)
Principal Display Panel (2 mL Ampule Label)
This text provides information about Fentanyl Citrate injection, which is intended for intramuscular use. The medication is supplied in 2mL vials containing 50 mcg per 1mL. It is important to protect the medication from light. The manufacturer is Hospira, Inc. located in Lake Forest, IL USA. The product should be retained in the carton until the time of use. Additionally, the text mentions the LOT number and expiration date of the medication.*
Principal Display Panel (2 mL Ampule Cello Pack Label)
This text describes a medication called Fentanyl Citrate Injection, USP, containing 100 mcg of Fentanyl per 2 mL vial. It provides instructions for storage, dosage, and usage for both intravenous and intramuscular administration. The medication is packaged in ampuls that should be kept in a tray until use, protected from light. The text also mentions the presence of pH adjustment and gives information on where it is distributed.*
Principal Display Panel (5 mL Ampule Label)
This is a description for a Fentanyl Citrate Injection, USP with a concentration of 250 mcg of Fentanyl per 5 mL. It is for Intravenous or Intramuscular use and should be protected from light. The product is distributed by Hospira, Inc. based in Lake Forest, IL. The lot number and expiration date are also provided.*
Principal Display Panel (5 mL Ampule Cello Pack Label)
Principal Display Panel (10 mL Ampule Label)
This is a description of a single-dose medication containing fentanyl citrate intended for intravenous use by hospital personnel specifically trained in its administration. Each mL of the medication contains 50 mcg of fentanyl citrate and may also include NaOH and HC1 for pH adjustment. The medication is stored at 20 to 25°C and should be protected from light. The NDC number is 0409-9093-41, and it is manufactured by Hospira Inc.*
Principal Display Panel (10 mL Ampule Carton)
This text provides information about a Fentanyl Citrate Injection solution with a strength of 500 mcg Fentanyl per 10 mL (or 50 mcg/mL). It contains directions for use, storage conditions (between 20 to 25°C), and precautions such as protecting from light and discarding any unused portion. The solution is intended for intravenous administration by hospital personnel trained in the use of narcotic analgesics. The manufacturer is Hospira. None of the text indicates non-English characters.*
Principal Display Panel (20 mL Ampule Label)
Description: This text provides information about a 20 mL single-dose vial containing fentanyl, with each mL containing 50 mcg (0.05 mg) of fentanyl as the citrate. It may contain NaOH and/or HCl for pH adjustment. The pH of the solution is 4.7. The product is to be protected from light, stored at 20 to 25°C (68 to 77°F), and retained in the carton until use. It is intended for intravenous use by hospital personnel trained in the use of narcotic analgesics. The manufacturer is Hospira, Inc. and the product should be discarded if unused.*
Principal Display Panel (20 mL Ampule Carton)
This is a description about a medication called Shaledose, which is a Fentanyl Citrate injection. It is available in a 20 mL vial, with each mL containing 50 mcg of fentanyl (as the citrate). The medication may contain sodium hydroxide and/or hydrochloric acid for pH adjustment. It is sterile and non-pyrogenic. The usual dose is to be determined based on the insert. The medication should be stored between 20 to 25°C. Patients are advised to protect the medication from light and discard any unused portions. It is recommended for intravenous administration by hospital personnel specifically trained in the use of narcotic analgesics. The package comes with a tamper-evident carton for inspection.*
Principal Display Panel (2 mL Vial Label)
This is a medication labeled as Fentanyl Citrate for intravenous or intramuscular use. Each vial contains 50 mg/mL of Fentanyl, with a total of 1IJI mcg of Fentanyl in 2 mL. The product is distributed by Hospira, Inc. in the USA. The packaging includes a GS1 DataBar and lot number information. The expiration date is indicated as YYYY-MMM.*
Principal Display Panel (2 mL Vial Tray Top)
This text provides information on a 2 mL injection vial containing Fentanyl Citrate with a concentration of 100 mcg Fentanyl per 2 mL (50 mcg/mL). The product is for Intravenous or Intramuscular use and should be protected from light. It is distributed by Hospira in Lake Forest, USA. It also indicates that the item is for prescription use only.*
Principal Display Panel (2 mL Vial Tray)
Principal Display Panel (5 mL Vial Label)
This is a description of a Fentanyl Citrate Injection, USP with a concentration of 250 mcg Fentanyl per 5 mL in a single-dose vial. The product is distributed by Hospira, Inc. with the National Drug Code (NDC) 04097909413. It is intended for prescription use only.*
Principal Display Panel (5 mL Vial Tray Top)
This is a prescription medication in the form of a 5 mL single-dose injection containing 250 mcg of Fentanyl Citrate per 5 mL (50 mcg/mL). The package includes 25 flip-top vials, each containing 25 units. The medication is intended for intravenous or intramuscular use and should be protected from light. It is distributed by Hospira, Inc. from Lake Forest, IL, USA. Unused portions should be discarded.*
Principal Display Panel (5 mL Vial Tray)
Principal Display Panel (10 mL Vial Label)
This text appears to be a description of a medication - Fentanyl Citrate in a 10 mL single-dose vial, with a concentration of 50 mcg/mL. The medication is distributed by Hospira, Inc. and is meant for intravenous use by hospital personnel trained in the use of narcotic analgesics. The text also provides information on storage conditions, dosage guidelines, and instructions for use. Discard unused portions and refer to the insert for usual dosage. Make sure to protect from light, retain in carton until use, and store at 20 to 25°C. Lot and expiration date details are also included.*
Principal Display Panel (10 mL Vial Tray)
This text is the label of a pharmaceutical product containing Fentanyl Citrate Injection, USP. The product is in 10 mL single-dose flip-top vials, with a concentration of 50 mcg/mL. It is for intravenous administration by hospital personnel trained in the use of narcotic analgesics. The usual dosage information is available in the insert. Storage instructions indicate storing at 20 to 25°C (68 to 77 °F). The product is distributed by Hospira, Inc.*
Principal Display Panel (20 mL Vial Label)
This text provides information about a 20mL Single-dose Vial of fentanyl citrate injection, USP, containing fentanyl at 50 mcg/mL concentration. The product is distributed by Hospira, Inc. and is recommended for intravenous use by hospital personnel trained in narcotic analgesics. The vial may contain NaOH and/or HCl for pH adjustment. The usual dosage should be confirmed using the insert, and the product should be protected from light until use and stored at 20°C to 25°C.*
Principal Display Panel (20 mL Vial Tray)
Not available*
Principal Display Panel (50 mL Vial Label)
Principal Display Panel (50 mL Vial Carton)
This is a detailed text about a medication containing fentanyl in mL vials. The information includes instructions for use, storage conditions, and dosage guidance. It specifies the concentration of fentanyl per mL as 50 mg/mL and provides details on handling and administration, highlighting the importance of expertise in using narcotics and opioids. The text also mentions removing the cover from the flip-top before use.*
Principal Display Panel (50 mL Vial Carton Tray)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
